| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |